 |
Iroko Pharmaceuticals, LLC
Navy Yard Corporate Center
One Crescent Drive
Suite 400
Philadelphia, PA 19112
p 267.546.3003
f 267.546.3004
Contact Us
|
|
Iroko Pharmaceuticals is an innovative, global company founded to acquire, develop and maximize the potential of currently marketed
pharmaceutical products. We are led by a senior management team of former executives of major pharmaceutical companies who offer extensive expertise in all
key aspects of the industry.
In early 2008, Iroko acquired the non-US commercial rights to Aggrastat® (tirofiban HCl) from Merck & Co., Inc. In addition to Aggrastat, Iroko has world-wide marketing rights to
Indocin® (indomethacin) and Aldomet® (methyldopa). Iroko also markets the oral antibiotic Vancocin® (vancomycin hydrochloride) in Canada.
These important acquisitions from major pharmaceutical companies form the platform from which Iroko will continue to grow in the months and years ahead.
Iroko Pharmaceuticals is dedicated to becoming the premier source of trusted brand-name pharmaceutical products. Our renewed efforts will assure that high-quality,
ethical products are easily accessed by healthcare providers and patients who can benefit most from their continued availability.
|
